NewslettersMay 02, 2025
Porton Newsletter - April 2025 Recap
Technical Enabling Services & Solutions Company Events Marketing Activities
NewslettersApr 11, 2025
Porton Newsletter - Q1 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities
NewslettersApr 11, 2025
Porton Newsletter - March 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities
NewslettersMar 06, 2025
Porton Newsletter - Jan. to Feb. 2025 Recap
Technical Enabling Technical Solutions for PROTAC Drugs Successful GMP Drug Product Delivery by Porton Biologics and Conjugates Platform
NewslettersDec 19, 2024
Porton Newsletter | Q4 2024 Recap
Porton Expands GMP Manufacturing and New Modality Services in Shanghai Fengxian Porton Successfully Hosts Ceremony for New Modality Capacity Upgrade Drug Modalities: Innovative Services & Solutions from Porton Pharma
NewslettersOct 01, 2024
Porton Newsletter | Q3 2024 Recap
Biologics and Conjugates CDMO Services Tides CDMO Services Porton J-STAR Cutting-Edge Technologies
NewslettersJul 07, 2024
Porton Newsletter | Q2 2024 Recap
Porton Pharma Solutions Embark on The Next Frontier in Mengeš, Slovenia. Announcement of New GMP HPAPI Lab and Integrated DS-DP Facilities at Porton J-STAR. Porton can provide one-stop CDMO services from PCC to IND and GMP clinical supply of ADC drugs for global pharmaceutical companies.
NewslettersMar 31, 2024
Porton Newsletter | Q1 2024 Recap
Porton PharmaTech (Slovenia)-B31 R&D Labs and Kilo lab Suites (non-GMP), expected to be completed in May 2024. New Facilities Will Be Ready in Porton USA / J-STAR Porton's Antibody and ADC GMP Pilot Manufactory Officially Operated
